Relapse Prevention Study in Patients With Schizophrenia

NCT01291511 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

635

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Iloperidone
DRUG: Placebo

Sponsor

Vanda Pharmaceuticals